Human T cell leukaemia virus type I env gene-transfected HeLa cells display a decrease in cell fusion ability

References

1. Ahmad A., Ladha A., Cohen E. A., Menezes J. 1993; Stable expression of the transfected HIV-1 env gene in a human B-cell line – characterization of gp 120-expressing clones and immunobiological studies. Virology 192:447–457
   [Google Scholar]
2. Bird C., Gleeson P. A., RAMSAY A., Li P., McCluskey I. 1992; Stable expression of the human immunodeficiency virus type-1 envelope glycoprotein in transfected L-cells. AIDS Research and Human Retroviruses 8:1999–2009
   [Google Scholar]
3. Carrington C. V. F., Weiss R. A., Schulz T. F. 1994; Truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions. Virology 202:61–69
   [Google Scholar]
4. Crise B., Buonocore L., Rose J. K. 1990; CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. Journal of Virology 64:5585–5593
   [Google Scholar]
5. Cullen B. R. 1992; Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiological Reviews 56:375–394
   [Google Scholar]
6. Delwart E. L., Panganiban A. T. 1989; Role of reticulo-endotheliosis virus envelope glycoprotein in superinfection interference. Journal of Virology 63:273–280
   [Google Scholar]
7. Fukudome K., Furuse M., Imaie T., Nishimura M., Takagi S., Hinuma Y., Yoshie O. 1992; Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-l)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-l-positive T cells. Journal of Virology 66:1394–1401
   [Google Scholar]
8. Gavalchin J., Fan N. S., Lane M. J., Papsidero L., Poiesz B. J. 1993; Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, mab 34–28. Virology 194:1–9
   [Google Scholar]
9. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., De The G. 1985; Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastical paraparesis. Lancet ii:407–410
   [Google Scholar]
10. Koga Y., Sasaki M., Yoshida H., Wigzell H., Kimura G., Nomoto K. 1990; Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. Journal of Immunology 144:94–102
    [Google Scholar]
11. Osame M., Usuku K., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara H. 1986; HTLV-I associated myelopathy: a new clinical entity. Lancet i:1031–1032
    [Google Scholar]
12. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. 1980; Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, USA 77:7415–7419
    [Google Scholar]
13. Sommerfelt M. A., Williams B. P., Clapham P. R., Solomon E., Goodfellow P. N., Weiss R. A. 1988; Human T-cell leukemia viruses use a common receptor encoded by human chromosome 17. Science 242:1557–1559
    [Google Scholar]
14. Stevenson M., Meier C., Mann A. M., Chapman N., Wasiak A. 1988; Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4 + cells: mechanism for persistence in AIDS. Cell 53:483–496
    [Google Scholar]
15. Vile R. G., Schulz T. F., Danos O. F., Collins M. K., Weiss R. A. 1991; A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene. Virology 180:420–424
    [Google Scholar]
16. Weiss R. A. 1993; Cellular receptors and viral glycoproteins involved in retrovirus entry. In The Retroviridae vol 2 pp 1–108 Edited by Levy J. A. New York: Plenum Press;
    [Google Scholar]